CESCA THERAPEUTICS INC. AMENDMENT NO. 1 TO THE convertible noteConvertible Note Agreement • July 29th, 2019 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture
Contract Type FiledJuly 29th, 2019 Company IndustryThis Amendment No. 1 (this “Amendment No. 1”) is made as of July 23, 2019 (the “Effective Date”) to the Convertible Note Agreement (the “Agreement”) dated January 29, 2019 by Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and Orbrex USA Co. Limited (“Orbrex”).